clinical trial

Mankind Pharma has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical…

The BD Libertas Wearable Injector is a prefilled, patient ready-to-use drug delivery system designed to enable delivery of complex…

GlobalData’s Q1 2025 report highlights ICON’s continued CRO dominance, Russia’s clinical trial volume lead in Europe, and…

The decision follows a pre-planned interim analysis which found that the trial would be unlikely to meet its primary objective of…

Amylyx explores new indications for Relyvrio after ALS trail setback, with early success in Wolfram syndrome and other…

Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib Puma Biotechnology, announced the…

Both low dose and high dose Vodobatinib arms did not meet the pre-specified primary endpoint of change in MDS-UPDRS Part III total…

The Phase-2 clinical trial of Ropanicant (SUVN-911) is for the treatment of moderate to severe Major Depressive Disorder (MDD)…

PCSK9 inhibitors, like VERVE-101, currently holds 20 per cent market share in the acute coronary syndrome market. PCSK9 inhibitors…

506 patients completed enrolment across 84 sites in the US, Europe and India